share_log

Piper Sandler Initiates Coverage On Gritstone Bio With Overweight Rating, Announces Price Target of $6

Piper Sandler Initiates Coverage On Gritstone Bio With Overweight Rating, Announces Price Target of $6

派珀·桑德勒以增持評級啓動對Gritstone Bio的報道,宣佈目標股價爲6美元
Benzinga Real-time News ·  2022/10/31 05:04

Piper Sandler analyst Edward Tenthoff initiates coverage on Gritstone Bio (NASDAQ:GRTS) with a Overweight rating and announces Price Target of $6.

派珀·桑德勒分析師愛德華·滕索夫以增持評級開始對Gritstone Bio(納斯達克股票代碼:GRTS)進行報道,並宣佈目標股價爲6美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論